{"id":4530,"date":"2025-10-01T16:26:43","date_gmt":"2025-10-01T06:26:43","guid":{"rendered":"https:\/\/harrison.ai\/?p=4530"},"modified":"2025-10-07T08:33:52","modified_gmt":"2025-10-06T21:33:52","slug":"how-technology-and-timing-came-together-for-a-potentially-life-saving-diagnosis","status":"publish","type":"post","link":"https:\/\/harrison.ai\/how-technology-and-timing-came-together-for-a-potentially-life-saving-diagnosis\/","title":{"rendered":"How technology and timing came together for a potentially life-saving diagnosis."},"content":{"rendered":"\n\n    <section id=\"news-content-2-block-block_840aa3b56acae6c6373f054d12e962c3\" class=\"content-block content-block--alt none text-\" >\n        <div class=\"container  container--tab\">\n            <div class=\"content b1 detail\" data-aos=\"fade-up\">\n                                <p>With lung cancer causing nearly 35,000 deaths in the UK each year<sup>[i]<\/sup>, the National Optimal Lung Cancer Pathway (NOLCP)<sup>[ii,iii]<\/sup> aims to improve outcomes by expediting lung cancer diagnosis. Developed by NHS England, it sets out tight timeframes for each stage of a best practice care pathway.<\/p>\n<p>While this pathway is specifically designed to accelerate detection of lung cancer cases, it sometimes helps to hasten detection of other pathologies that may be equally critical.<\/p>\n<p>The introduction of Harrison.ai CXR<sup>[iv]<\/sup> has strengthened the system, allowing even the most subtle findings to be detected. In one instance, this occurred within just hours of the solution being deployed in the care pathway.<\/p>\n<h5>Understanding the Care Pathway<\/h5>\n<p><span data-teams=\"true\">The standard care pathway at Trusts ensures a streamlined process for patients referred by GPs. Here\u2019s how it works:<\/span><\/p>\n<ul>\n<li>Patient referred by GP presents a request form.<\/li>\n<li>The imaging request is justified and the x-ray acquired by a radiographer.<\/li>\n<li>The acquiring radiography team conducts preliminary clinical evaluation (PCE) of the images.<\/li>\n<\/ul>\n<p>What happens next depends on the preliminary findings.<\/p>\n<ul>\n<li>If the CXR looks normal on initial review, the patient is sent home to await the formal imaging report.<\/li>\n<li>If potential abnormalities are identified, the radiographer flags the case for further review by a reporting radiographer or radiologist accelerating the care pathway.<\/li>\n<\/ul>\n<h3>Case Presentation<\/h3>\n<p><span data-teams=\"true\">A male adult in his 20s presented to the North Tees and Hartlepool NHS Foundation Trust hospital with a history of persistent cough and underwent a chest radiograph (CXR) as requested by his GP. The acquiring radiographers did not identify any abnormalities during their PCE. The patient was sent home, consistent with existing protocols.<\/span><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full width100 wp-image-3684\" src=\"https:\/\/harrison.ai\/wp-content\/uploads\/2025\/09\/body.png\" alt=\"body\" width=\"657\" height=\"468\" srcset=\"https:\/\/harrison.ai\/wp-content\/uploads\/2025\/09\/body.png 657w, https:\/\/harrison.ai\/wp-content\/uploads\/2025\/09\/body-460x328.png 460w\" sizes=\"auto, (max-width: 657px) 100vw, 657px\" \/><\/p>\n<p>Disclaimer: Harrison.ai chest X-ray (CXR) was previously marketed as Annalise Enterprise.<\/p>\n<h3>Remarkable Timing for a Seemingly Unremarkable Case<\/h3>\n<p>Just minutes before this patient\u2019s CXR was taken, the Harrison.ai team were in the process of activating Harrison.ai Chest X-ray (CXR) at the site, having completed all testing. The solution had started prioritising cases based on the severity of findings, pushing critical cases to the top of the reporting radiographer\u2019s worklist.<\/p>\n<p>Shortly after the patient\u2019s departure and with Harrison.ai CXR now enabled, the reporting radiographer spotted this specific case at the top of the reporting worklist\u2014with a critical priority flagged by the AI.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full width100 wp-image-3694\" src=\"https:\/\/harrison.ai\/wp-content\/uploads\/2025\/06\/image-2.png\" alt=\"image-2\" width=\"657\" height=\"468\" srcset=\"https:\/\/harrison.ai\/wp-content\/uploads\/2025\/06\/image-2.png 657w, https:\/\/harrison.ai\/wp-content\/uploads\/2025\/06\/image-2-460x328.png 460w\" sizes=\"auto, (max-width: 657px) 100vw, 657px\" \/><\/p>\n<p>Disclaimer: Harrison.ai chest X-ray (CXR) was previously marketed as Annalise Enterprise.<\/p>\n<p>Harrison.ai CXR identified 3 critical findings, including hilar lymphadenopathy, superior mediastinal mass and inferior mediastinal mass.<\/p>\n<p>The reporting radiographer immediately reviewed the flagged case and agreed with Harrison.ai CXR\u2019s findings, scheduling the patient\u2019s CT scan for the next day. The radiographic appearances indicated a range of potential diagnoses including lymphoma, a significant concern that necessitated urgent follow-up. This change in workflow meant that instead of waiting for reporting in a chronological order (which could take up to a few days depending on staffing levels and CXR volumes), the patient\u2019s images were reported almost immediately. This rapid response helped to ensure timely diagnosis and intervention, potentially saving days on the patient\u2019s pathway.<\/p>\n<h3>Follow Up Action and Patient Management<\/h3>\n<h4>Step 1<\/h4>\n<p><span data-teams=\"true\">The patient underwent a CT scan the following day. A multilocular cystic mass was identified on CT in the mediastinum, accompanied by numerous enlarged lymph nodes located centrally in the chest.<\/span><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full width100 wp-image-3695\" src=\"https:\/\/harrison.ai\/wp-content\/uploads\/2025\/06\/image-3.png\" alt=\"image-3\" width=\"596\" height=\"377\" srcset=\"https:\/\/harrison.ai\/wp-content\/uploads\/2025\/06\/image-3.png 596w, https:\/\/harrison.ai\/wp-content\/uploads\/2025\/06\/image-3-460x291.png 460w\" sizes=\"auto, (max-width: 596px) 100vw, 596px\" \/><\/p>\n<h4>Step 2<\/h4>\n<p>A PET CT scan was subsequently performed. It demonstrated marked metabolic activity, indicating an aggressive process.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full width100 wp-image-3696\" src=\"https:\/\/harrison.ai\/wp-content\/uploads\/2025\/06\/image-4.png\" alt=\"image-4\" width=\"596\" height=\"373\" srcset=\"https:\/\/harrison.ai\/wp-content\/uploads\/2025\/06\/image-4.png 596w, https:\/\/harrison.ai\/wp-content\/uploads\/2025\/06\/image-4-460x288.png 460w\" sizes=\"auto, (max-width: 596px) 100vw, 596px\" \/><\/p>\n<h3><span data-teams=\"true\">Harrison.ai: Improving Workflows and Patient Outcomes<\/span><\/h3>\n<p><span data-teams=\"true\">Implementing an AI-enhanced workflow had an immediate positive impact on departmental efficiency and patient outcomes.<\/span><\/p>\n<h4>Improved Patient Outcomes and Reduced Delays<\/h4>\n<p><span data-teams=\"true\">Relying solely on chronological report sequences could lead to delayed investigation and treatment, potentially affecting cancer staging, treatment options, and overall prognosis. The introduction of AI reduces this risk by expediting the diagnostic process.<\/span><\/p>\n<h4><span data-teams=\"true\">Worklist Prioritisation<\/span><\/h4>\n<p><span data-teams=\"true\">Even in a department with an established same-day CT pathway, worklist prioritisation proved immediately valuable, helping ensure that a critical priority case received timely attention. Worklist triage helps draw the attention of acquiring radiographers to prioritise potential cases of clinical significance, ensuring more subtle presentations are not overlooked. This minimises the risk of missed findings, thereby improving diagnostic accuracy.<\/span><\/p>\n<h4><span data-teams=\"true\">Enhanced Workflows Help National Standards to be Met<\/span><\/h4>\n<p><span data-teams=\"true\">The integration of an AI-enhanced workflow proved instrumental in the timely detection and follow-up for this patient.<\/span><\/p>\n                                <div class=\"section-small-text\">\n                    <section class=\"l-section wpb_row remarkable_content_sec9 height_medium width_full\">\n<div class=\"l-section-h i-cf\">\n<div class=\"g-cols vc_row via_grid cols_1 laptops-cols_inherit tablets-cols_inherit mobiles-cols_1 valign_top type_default stacking_default\">\n<div class=\"wpb_column vc_column_container\">\n<div class=\"vc_column-inner\">\n<div class=\"wpb_text_column\">\n<div class=\"wpb_wrapper\">\n<p>References<br \/>\n[i] Cancer Research UK. Lung cancer statistics. Cancer Research UK. <a id=\"menurnjm\" class=\"fui-Link ___1q1shib f2hkw1w f3rmtva f1ewtqcl fyind8e f1k6fduh f1w7gpdv fk6fouc fjoy568 figsok6 f1s184ao f1mk8lai fnbmjn9 f1o700av f13mvf36 f1cmlufx f9n3di6 f1ids18y f1tx3yz7 f1deo86v f1eh06m1 f1iescvh fhgqx19 f1olyrje f1p93eir f1nev41a f1h8hb77 f1lqvz6u f10aw75t fsle3fq f17ae5zn\" title=\"https:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-bycancer-type\/lung-cancer\" href=\"https:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-bycancer-type\/lung-cancer\" target=\"_blank\" rel=\"noreferrer noopener\" aria-label=\"Link https:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-bycancer-type\/lung-cancer\">https:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-bycancer-type\/lung-cancer<\/a>.<\/p>\n<p>[ii,iii] NOLCP Implementation Guide. <a id=\"menurnjo\" class=\"fui-Link ___1q1shib f2hkw1w f3rmtva f1ewtqcl fyind8e f1k6fduh f1w7gpdv fk6fouc fjoy568 figsok6 f1s184ao f1mk8lai fnbmjn9 f1o700av f13mvf36 f1cmlufx f9n3di6 f1ids18y f1tx3yz7 f1deo86v f1eh06m1 f1iescvh fhgqx19 f1olyrje f1p93eir f1nev41a f1h8hb77 f1lqvz6u f10aw75t fsle3fq f17ae5zn\" title=\"https:\/\/www.roycastle.org\/app\/uploads\/2019\/07\/lung_cancer_implementation_guide_august_2017.pdf\" href=\"https:\/\/www.roycastle.org\/app\/uploads\/2019\/07\/Lung_Cancer_Implementation_Guide_August_2017.pdf\" target=\"_blank\" rel=\"noreferrer noopener\" aria-label=\"Link https:\/\/www.roycastle.org\/app\/uploads\/2019\/07\/Lung_Cancer_Implementation_Guide_August_2017.pdf\">https:\/\/www.roycastle.org\/app\/uploads\/2019\/07\/Lung_Cancer_Implementation_Guide_August_2017.pdf<\/a>.<\/p>\n<p>[iv] SoR news article. <a id=\"menurnjq\" class=\"fui-Link ___1q1shib f2hkw1w f3rmtva f1ewtqcl fyind8e f1k6fduh f1w7gpdv fk6fouc fjoy568 figsok6 f1s184ao f1mk8lai fnbmjn9 f1o700av f13mvf36 f1cmlufx f9n3di6 f1ids18y f1tx3yz7 f1deo86v f1eh06m1 f1iescvh fhgqx19 f1olyrje f1p93eir f1nev41a f1h8hb77 f1lqvz6u f10aw75t fsle3fq f17ae5zn\" title=\"https:\/\/www.sor.org\/news\/x-ray\/teesside-hospital-rolls-out-artificial-intelligenc\" href=\"https:\/\/www.sor.org\/news\/x-ray\/teesside-hospital-rolls-out-artificial-intelligenc\" target=\"_blank\" rel=\"noreferrer noopener\" aria-label=\"Link https:\/\/www.sor.org\/news\/x-ray\/teesside-hospital-rolls-out-artificial-intelligenc\">https:\/\/www.sor.org\/news\/x-ray\/teesside-hospital-rolls-out-artificial-intelligenc<\/a><\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/section>\n<p>&nbsp;<\/p>\n<p>Disclaimer: Harrison.ai chest X-ray (CXR) was previously marketed as Annalise Enterprise and Annalise Container.<\/p>\n                <\/div>\n                \n            <\/div>\n        <\/div>\n    <\/section>\n\n\n\n    <section id=\"news-discuss-block-block_f5f90ee5b825a69d874de6d2beafcb99\" class=\"discuss-block discuss-block--transparent   text-\" >\n        <div class=\"container  container-\">\n\n            <div class=\"discuss__card\" data-aos=\"fade-up\">\n                                                            <div class=\"discuss__left\">\n                            <h2 class=\"h4 mb-0 ls-0\">Ready to discuss how AI could drive clinical and financial outcomes for your organisation? <\/h2>\n                        <\/div>\n                                                                <div class=\"discuss__btn\">\n                            <a href=\"#bookademo\" target=\"_self\" class=\"btn font-rules\">Book a demo <span class=\"icon-arrow-right-up\"><\/span><\/a>\n                        <\/div>\n                                    \n            <\/div>\n        <\/div>\n    <\/section>\n\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":3,"featured_media":583,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[28],"tags":[],"region":[36],"product":[40],"class_list":["post-4530","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-case-studies","region-uk","product-cxr"],"acf":[],"_links":{"self":[{"href":"https:\/\/harrison.ai\/wp-json\/wp\/v2\/posts\/4530","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/harrison.ai\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/harrison.ai\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/harrison.ai\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/harrison.ai\/wp-json\/wp\/v2\/comments?post=4530"}],"version-history":[{"count":5,"href":"https:\/\/harrison.ai\/wp-json\/wp\/v2\/posts\/4530\/revisions"}],"predecessor-version":[{"id":5265,"href":"https:\/\/harrison.ai\/wp-json\/wp\/v2\/posts\/4530\/revisions\/5265"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/harrison.ai\/wp-json\/wp\/v2\/media\/583"}],"wp:attachment":[{"href":"https:\/\/harrison.ai\/wp-json\/wp\/v2\/media?parent=4530"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/harrison.ai\/wp-json\/wp\/v2\/categories?post=4530"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/harrison.ai\/wp-json\/wp\/v2\/tags?post=4530"},{"taxonomy":"region","embeddable":true,"href":"https:\/\/harrison.ai\/wp-json\/wp\/v2\/region?post=4530"},{"taxonomy":"product","embeddable":true,"href":"https:\/\/harrison.ai\/wp-json\/wp\/v2\/product?post=4530"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}